| 1 | NKTR | Nektar Therapeutics FY · 2025-12-31 | Pharmaceuticals | $1.4B | 100.0% |
| 2 | MGNX | MACROGENICS, INC. FY · 2025-12-31 | Pharmaceuticals | $237M | 100.0% |
| 3 | ABVC | ABVC BioPharma, Inc. FY · 2024-12-31 | Pharmaceuticals | $26M | 99.9% |
| 4 | LXRX | LEXICON PHARMACEUTICALS, INC. FY · 2025-12-31 | Pharmaceuticals | $734M | 99.4% |
| 5 | IBRX | IMMUNITYBIO, INC. FY · 2025-12-31 | Pharmaceuticals | $10.7B | 99.3% |
| 6 | AGEN | AGENUS INC FY · 2025-12-31 | Pharmaceuticals | $336M | 99.1% |
| 7 | CORT | CORCEPT THERAPEUTICS INC TTM · 2026-06-30 | Pharmaceuticals | $13.1B | 98.3% |
| 8 | IONS | IONIS PHARMACEUTICALS, INC. TTM · 2026-06-30 | Pharmaceuticals | $7.3B | 98.2% |
| 9 | NBIX | NEUROCRINE BIOSCIENCES, INC. TTM · 2026-06-30 | Pharmaceuticals | $14.4B | 98.0% |
| 10 | BCRX | BIOCRYST PHARMACEUTICALS, INC. TTM · 2026-06-30 | Pharmaceuticals | $2.1B | 97.8% |
| 11 | EXEL | Exelixis Inc TTM · 2026-07-03 | Pharmaceuticals | $14.8B | 96.5% |
| 12 | GYRE | Gyre Therapeutics, Inc. FY · 2025-12-31 | Pharmaceuticals | $728M | 95.4% |
| 13 | RIGL | RIGEL PHARMACEUTICALS, INC. TTM · 2026-06-30 | Pharmaceuticals | $912M | 91.4% |
| 14 | ACAD | ACADIA PHARMACEUTICALS INC. TTM · 2026-06-30 | Pharmaceuticals | $3.3B | 91.1% |
| 15 | MNKD | MannKind Corporation TTM · 2026-06-30 | Pharmaceuticals | $1.0B | 89.8% |
| 16 | NNNN | Anbio Biotechnology FY · 2025-12-31 | Biotechnology | $194M | 87.2% |
| 17 | CLDX | Celldex Therapeutics, Inc. FY · 2025-12-31 | Biotechnology | $2.3B | 87.1% |
| 18 | CDXS | Codexis, Inc. TTM · 2026-06-30 | Other | $154M | 87.0% |
| 19 | VRTX | VERTEX PHARMACEUTICALS INC / MA FY · 2025-12-31 | Pharmaceuticals | $128.5B | 86.2% |
| 20 | UTHR | United Therapeutics Corporation TTM · 2026-06-30 | Pharmaceuticals | $23.6B | 86.1% |
| 21 | CPIX | Cumberland Pharmaceuticals Inc. FY · 2025-12-31 | Pharmaceuticals | $105M | 85.0% |
| 22 | ERNA | Ernexa Therapeutics Inc. FY · 2024-12-31 | Pharmaceuticals | $3M | 83.5% |
| 23 | INSM | INSMED INC TTM · 2026-06-30 | Pharmaceuticals | $21.5B | 83.5% |
| 24 | LLY | ELI LILLY AND COMPANY FY · 2025-12-31 | Pharmaceuticals | $1.1T | 83.0% |
| 25 | HALO | HALOZYME THERAPEUTICS, INC. TTM · 2026-06-30 | Pharmaceuticals | $12.6B | 82.4% |
| 26 | TGTX | TG THERAPEUTICS, INC. TTM · 2026-06-30 | Pharmaceuticals | $8.5B | 82.4% |
| 27 | ALNY | ALNYLAM PHARMACEUTICALS, INC. TTM · 2026-06-30 | Pharmaceuticals | $30.4B | 79.8% |
| 28 | GILD | GILEAD SCIENCES, INC. TTM · 2026-06-30 | Pharmaceuticals | $186.5B | 79.6% |
| 29 | NVAX | NOVAVAX, INC. TTM · 2026-06-30 | Pharmaceuticals | $2.1B | 78.6% |
| 30 | LFVN | LIFEVANTAGE CORP FY · 2026-06-30 | Pharmaceuticals | $75M | 77.6% |
| 31 | USNA | USANA HEALTH SCIENCES, INC. TTM · 2026-07-04 | Pharmaceuticals | $276M | 77.4% |
| 32 | BMRN | BIOMARIN PHARMACEUTICAL INC TTM · 2026-06-30 | Pharmaceuticals | $10.7B | 76.1% |
| 33 | EL | Estee Lauder Companies Inc FY · 2026-06-30 | Other | $36.2B | 75.5% |
| 34 | BIIB | BIOGEN INC. TTM · 2026-03-31 | Pharmaceuticals | $33.9B | 75.5% |
| 35 | MTEX | MANNATECH INC FY · 2025-12-31 | Pharmaceuticals | $15M | 74.9% |
| 36 | INVA | INNOVIVA, INC. FY · 2025-12-31 | Pharmaceuticals | $1.5B | 74.8% |
| 37 | VCEL | VERICEL CORPORATION FY · 2025-12-31 | Pharmaceuticals | $2.1B | 74.4% |
| 38 | ABEO | ABEONA THERAPEUTICS INC. FY · 2025-12-31 | Pharmaceuticals | $280M | 73.7% |
| 39 | HRTX | HERON THERAPEUTICS, INC. /DE/ FY · 2025-12-31 | Pharmaceuticals | $79M | 73.3% |
| 40 | PFE | PFIZER INC TTM · 2026-06-28 | Pharmaceuticals | $161.9B | 73.2% |
| 41 | NATR | NATURE’S SUNSHINE PRODUCTS, INC. TTM · 2026-06-30 | Pharmaceuticals | $224M | 73.2% |
| 42 | MRK | Merck & Co., Inc. TTM · 2026-06-30 | Pharmaceuticals | $358.9B | 73.0% |
| 43 | ZTS | Zoetis Inc. TTM · 2026-06-30 | Pharmaceuticals | $31.3B | 71.5% |
| 44 | BMY | BRISTOL-MYERS SQUIBB COMPANY TTM · 2026-06-30 | Pharmaceuticals | $117.6B | 70.2% |
| 45 | AMGN | Amgen Inc. TTM · 2026-06-30 | Pharmaceuticals | $225.8B | 69.5% |
| 46 | PLX | PROTALIX BIOTHERAPEUTICS, INC. TTM · 2026-06-30 | Pharmaceuticals | $224M | 69.2% |
| 47 | MYGN | MYRIAD GENETICS, INC. TTM · 2026-06-30 | Biotechnology | $402M | 68.8% |
| 48 | BTMD | biote Corp. TTM · 2026-06-30 | Pharmaceuticals | $33M | 68.6% |
| 49 | JNJ | Johnson & Johnson FY · 2025-12-28 | Pharmaceuticals | $635.6B | 67.9% |
| 50 | CELZ | Creative Medical Technology Holdings, Inc. TTM · 2026-06-30 | Pharmaceuticals | $6M | 66.9% |
| 51 | TECH | BIO-TECHNE Corp FY · 2026-06-30 | Pharmaceuticals | $11.4B | 65.8% |
| 52 | SNYR | SYNERGY CHC CORP. TTM · 2026-03-31 | Pharmaceuticals | $1M | 65.4% |
| 53 | NAGE | NIAGEN BIOSCIENCE, INC. TTM · 2026-06-30 | Pharmaceuticals | $208M | 64.2% |
| 54 | IPAR | INTERPARFUMS, INC. TTM · 2026-06-30 | Other | $3.6B | 63.8% |
| 55 | COTY | | Other | $2.6B | 62.9% |
| 56 | IDXX | IDEXX LABORATORIES INC /DE TTM · 2026-06-30 | Biotechnology | $41.3B | 62.4% |
| 57 | CL | COLGATE-PALMOLIVE COMPANY TTM · 2026-06-30 | Other | $71.7B | 60.4% |
| 58 | ANIP | ANI PHARMACEUTICALS, INC TTM · 2026-06-30 | Pharmaceuticals | $1.7B | 60.4% |
| 59 | LNTH | LANTHEUS HOLDINGS, INC. TTM · 2026-06-30 | Biotechnology | $6.5B | 60.1% |
| 60 | KVUE | Kenvue Inc. TTM · 2026-06-28 | Other | $34.2B | 58.2% |
| 61 | AMRN | AMARIN CORP PLC\UK FY · 2025-12-31 | Pharmaceuticals | $244M | 56.6% |
| 62 | ABT | ABBOTT LABORATORIES TTM · 2026-03-31 | Pharmaceuticals | $176.2B | 56.3% |
| 63 | WDFC | WD-40 COMPANY TTM · 2026-05-31 | Other | $2.7B | 55.8% |
| 64 | SIGA | Siga Technologies INC TTM · 2026-06-30 | Pharmaceuticals | $227M | 54.4% |
| 65 | RGEN | REPLIGEN CORP TTM · 2026-06-30 | Pharmaceuticals | $11.0B | 53.8% |
| 66 | TOMZ | TOMI ENVIRONMENTAL SOLUTIONS, INC. TTM · 2026-06-30 | Other | $12M | 52.9% |
| 67 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LIMITED FY · 2025-12-31 | Pharmaceuticals | $48.0B | 51.8% |
| 68 | PG | PROCTER & GAMBLE CO FY · 2026-06-30 | Other | $355.8B | 50.2% |
| 69 | LAB | Standard BioTools Inc. FY · 2025-12-31 | Pharmaceuticals | $258M | 49.9% |
| 70 | CSBR | CHAMPIONS ONCOLOGY, INC. TTM · 2026-07-31 | Pharmaceuticals | $69M | 49.8% |
| 71 | LIN | Linde plc TTM · 2026-06-30 | Other | $224.7B | 48.3% |
| 72 | IMDX | Insight Molecular Diagnostics Inc. TTM · 2026-06-30 | Biotechnology | $104M | 47.6% |
| 73 | CYRX | CRYOPORT, INC. TTM · 2026-06-30 | Pharmaceuticals | $853M | 47.1% |
| 74 | NEOG | Neogen Corporation FY · 2026-05-31 | Biotechnology | $2.6B | 46.9% |
| 75 | UG | UNITED-GUARDIAN, INC. TTM · 2026-06-30 | Other | $32M | 46.9% |
| 76 | CRON | CRONOS GROUP INC. TTM · 2026-06-30 | Pharmaceuticals | $1.2B | 45.9% |
| 77 | CHD | CHURCH & DWIGHT CO., INC. FY · 2025-12-31 | Other | $23.7B | 44.7% |
| 78 | QDEL | QUIDELORTHO CORP TTM · 2026-06-28 | Biotechnology | $909M | 44.6% |
| 79 | PLUR | PLURI INC. FY · 2026-06-30 | Pharmaceuticals | $12M | 44.6% |
| 80 | ECL | ECOLAB INC. TTM · 2026-06-30 | Other | $79.7B | 44.1% |
| 81 | CLX | CLOROX CO /DE/ TTM · 2026-03-31 | Other | $10.2B | 43.8% |
| 82 | CF | CF INDUSTRIES HOLDINGS, INC. TTM · 2026-06-30 | Other | $17.3B | 42.5% |
| 83 | ICCC | ImmuCell Corporation FY · 2025-12-31 | Biotechnology | $87M | 41.4% |
| 84 | PPG | PPG INDUSTRIES INC TTM · 2026-03-31 | Other | $23.1B | 41.4% |
| 85 | RPM | RPM International Inc. TTM · 2026-08-31 | Other | $12.4B | 41.1% |
| 86 | OPK | OPKO Health, Inc. TTM · 2026-06-30 | Pharmaceuticals | $1.0B | 40.8% |
| 87 | EPC | EDGEWELL PERSONAL CARE COMPANY TTM · 2026-06-30 | Other | $1.3B | 40.4% |
| 88 | IFF | INTERNATIONAL FLAVORS & FRAGRANCES INC TTM · 2026-06-30 | Other | $21.7B | 38.9% |
| 89 | FTLF | FITLIFE BRANDS, INC. TTM · 2026-06-30 | Pharmaceuticals | $87M | 36.5% |
| 90 | BCPC | Balchem Corporation TTM · 2026-06-30 | Pharmaceuticals | $5.4B | 36.3% |
| 91 | FMC | FMC CORPORATION TTM · 2026-06-30 | Pharmaceuticals | $1.3B | 35.3% |
| 92 | VTRS | VIATRIS INC. TTM · 2026-06-30 | Pharmaceuticals | $20.1B | 34.9% |
| 93 | TRIB | TRINITY BIOTECH PLC FY · 2024-12-31 | Biotechnology | $5M | 34.8% |
| 94 | SXT | Sensient Technologies Corp TTM · 2026-06-30 | Other | $5.5B | 34.6% |
| 95 | TKNO | ALPHA TEKNOVA, INC. TTM · 2026-06-30 | Biotechnology | $467M | 34.6% |
| 96 | PAHC | Phibro Animal Health Corporation FY · 2026-06-30 | Pharmaceuticals | $1.5B | 33.8% |
| 97 | FUL | FULLER H B CO TTM · 2026-08-29 | Other | $2.7B | 32.3% |
| 98 | SMG | Scotts Miracle-Gro Co TTM · 2026-06-27 | Other | $2.9B | 32.3% |
| 99 | ROG | ROGERS CORP TTM · 2026-03-31 | Other | $2.6B | 32.2% |
| 100 | SOLS | Solstice Advanced Materials Inc. FY · 2025-12-31 | Pharmaceuticals | $9.6B | 32.2% |